Obesity medicines are needed in SA’s public sector. Can our government provide them?

In South Africa, access to weight loss medicines like Ozempic and Mounjaro remains limited to those who can shell out a few thousand Rand a month. In the second article of a Spotlight special series, Catherine Tomlinson looks at the medical need for these medicines in the country and what it would take for government to provide them in the public sector.

Read More

Blockbuster weight-loss and diabetes medicines sales surge despite cost barriers

Sales of weight loss medicines like Ozempic and Mounjaro have sky-rocketed in South Africa in recent years, although they remain too expensive for most people who might benefit from the jabs. In the first article of this Spotlight special series, Catherine Tomlinson tracks their remarkable rise and assesses when they will become more widely available here.

Read More

Rates of obesity are soaring worldwide: Have we been misunderstanding the problem?

Authors of a recent Lancet report argue that obesity should not just be seen as a risk factor for other diseases – but in some cases, should be seen as a disease itself. The position could change how we treat obesity globally. In the first of this two-part Spotlight series, Jesse Copelyn breaks down the debate around the issue, and its implications for health policy.

Read More

Poorly controlled diabetes is a top killer, time to take it more seriously

The South African government has adopted a national target to bring the blood sugar levels of people with diabetes under control. But beyond the target, the country’s response to diabetes is falling far short. In this Spotlight special briefing, Catherine Tomlinson looks at what the country needs to do to better manage this often fatal disease and how we can draw lessons from the response to HIV.

Read More

Analysis: Taking a spoon to a knife fight – Is SA ready for rising obesity rates?

Experts describe rising obesity rates in South Africa as an “urgent crisis”, “a tsunami” – even an “epidemic” – that is costing lives, not to mention billions of rands. Tackling the situation warrants an action plan that is as comprehensive and cogent as the problem is dire. But does the new national strategy fit the bill? Amy Green asked several local experts.

Read More